Sort
16,300 grants matching “fatty liver disease”
Epigenomic regulation of metabolism in muscle by circadian clock and environment
$7,395Zheng Sun · University Of Pennsylvania · K99 · FY2014 · DK
XENOBIOTIC BIOTRANSFORMATION IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE
$7,360Joel Edward Lavine · University Of California, San Diego · M01 · FY2009 · RR
CLINICAL TRIAL: PHASE II TRIAL OF IDB 1016 IN ADULT DIABETIC PATIENTS WITH NASH
$7,327Heather Patton · University Of California, San Diego · M01 · FY2008 · RR
THE ROLE OF DE-NOVO LIPOGENESIS IN NON-ALCOHOL FATTY LIVER DISEASE
$7,273John N Clore · Virginia Commonwealth University · M01 · FY2006 · RR
High-throughput chemoenzymatic synthesis of bioactive compounds
$6,911Joshua Pyser · University Of Michigan At Ann Arbor · F31 · FY2021 · GM
TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN CHILDREN
$6,851Parvathi Mohan · Children'S Research Institute · M01 · FY2010 · RR
FAK regulation of cholesterol influx and efflux in foam cells
$6,704Steve Lim · University Of South Alabama · R01 · FY2022 · HL
Role of stearoyl CoA desaturase-1 in TLR5 KO mice colitis and metabolic syndrome
$6,636Matam Vijay-Kumar · Georgia State University · R03 · FY2013 · DK
Liver Cancer (LC) (Project-003)
$6,566Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · P30 · FY2015 · CA
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
$6,548University Of California San Francisco · M01 · FY2005 · RR
SKELETAL MUSCLE DE NOVO LIPOGENESIS AND THE GLUCOSE-FATTY ACID CYCLE
$6,516Katsuhiko Funai · Washington University · K01 · FY2013 · DK
TARGETED MS FOR DETECTION OF LIVER ENZYMES IN FATTY LIVER DISEASE
$6,458Christine Wu Nordahl · University Of Washington · P41 · FY2011 · RR
Epigenetics and the Origin of Muscle Insulin Resistance in Humans
$6,447Dawn Katrina Coletta · Arizona State University-Tempe Campus · R01 · FY2016 · DK
THE ROLE OF DE-NOVO LIPOGENESIS IN NON-ALCOHOL FATTY LIVER DISEASE
$6,321John N Clore · Virginia Commonwealth University · M01 · FY2007 · RR
EXERCISE AND PIOGLITAZONE FOR HIV-METABOLIC SYNDROMES
$6,132Kevin E Yarasheski · Washington University · P41 · FY2008 · RR
EFFECTS OF SAM IN PATIENTS WITH ALCOHOLIC LIVER DISEASE
$6,072University Of California Davis · M01 · FY2004 · RR
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$6,000Joannes B Hoek · Thomas Jefferson University · R01 · FY2011 · AA
TRIAL OF BETAINE IN PTS WITH NONALCOHOLIC STEATOHEPATIS
$5,897Manal F. Abdelmalek · University Of Florida · M01 · FY2007 · RR
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging
$5,817Nir J Barzilai · Albert Einstein College Of Medicine · P30 · FY2015 · AG
COLLECTION AND BANKING OF BIOLOGICAL SPECIMENS
$5,723Thomas Harris Inge · Cincinnati Childrens Hosp Med Ctr · M01 · FY2008 · RR
Signaling and Biotechology Program
$5,639Hui-Kuan Lin · Wake Forest University Health Sciences · P30 · FY2019 · CA
FATTY LIVER DISEASE AND HEPATIC ENERGY HOMEOSTASIS IN LOOK AHEAD
$5,480Jeanne M Clark · Johns Hopkins University · M01 · FY2006 · RR
Pilot Project
$5,408Pierre Michel Gholam · Cleveland Clinic Lerner Com-Cwru · P20 · FY2013 · AA
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE
$5,406Kris Kowdley · University Of Washington · M01 · FY2007 · RR
Treating secondary cardiomyopathies by mimicking the adaptive hepatic glucose fasting response
$5,050Brian Jesse Debosch · Washington University · R01 · FY2024 · HL